913652-22-9

Upstream product

• 149428-98-8 (5-chloro-2-((phenylmethyl)oxy)phenyl)acetic acid 
• 100-39-0 benzyl bromide 
• 42972-62-3 1-<5-chloro-2-(phenylmethoxy)phenyl>ethanone 
• 913650-10-9 2-(5-chloro-2-[(phenylmethyl)oxy]phenyl)ethanethioamide 
• 913649-93-1 ethyl (5-chloro-2-((phenylmethyl)oxy)phenyl)acetate 
• 1450-74-4 5-chloro-2-hydroxyacetophenone 
• 913651-21-5 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazole-4-carboxylic acid 
• 913652-13-8 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazole-4-carboxamide 
• 67-56-1 methanol 
• 913652-12-7 2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazole-4-carbonitrile 

Downstream Products

• 913653-00-6 2-(2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazol-4-yl)-5-(4-methyl-1-piperazinyl)-3H-benzimidazole hydrochloride 
• 913652-93-4 2-(2-(2-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-1,3-thiazol-4-yl)-3H-benzimidazol-5-yl)ethanol 

Relevant academic research and scientific papers

OXAZOLE AND THIAZOLE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PGE2 MEDIATED DISORDERS

Compounds of formula (I) or a pharmaceutiically acceptable derivative thereof: wherein X, Z, Y', Y'', R1 ,R2a, R2b, and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.